Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Globus Medical (GMED) is an Incredible Growth Stock: 3 Reasons Why
01:46pm, Friday, 14'th Nov 2025
Globus Medical (GMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
10:51am, Friday, 14'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Medical Products Leader In Base After 36% Stock Surge On Blowout Quarterly Earnings
10:15am, Friday, 14'th Nov 2025
Globus Medical's spine business is a big earnings driver, propelling its stock closer to a buy point.
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy?
10:46am, Tuesday, 11'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Globus Medical: Straightening Its Back
10:00am, Tuesday, 11'th Nov 2025
Globus Medical has rebounded strongly, driven by accelerating earnings and successful integration of acquisitions like NuVasive and Nevro. The company delivered on robust Q3 results, with 7% organic g
Globus Medical Stock Soars After Earnings. Where It's Seeing the Strength.
11:08am, Friday, 07'th Nov 2025
Shares of the medical technology company are headed for their largest same-day percentage increase on record.
Today's Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical
10:04am, Friday, 07'th Nov 2025
The image featured for this article is © Thinkstock
Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript
09:56pm, Thursday, 06'th Nov 2025
Globus Medical, Inc. ( GMED ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Brian Kearns - Senior Vice President of Business Development & Investor Relations Keith Pfeil - CE
Globus Medical (GMED) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
08:31pm, Thursday, 06'th Nov 2025
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Stre
Globus Medical (GMED) Tops Q3 Earnings and Revenue Estimates
07:55pm, Thursday, 06'th Nov 2025
Globus Medical (GMED) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.83 per share a year ago.
Globus Medical Reports Third Quarter 2025 Results
04:15pm, Thursday, 06'th Nov 2025
AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30
Globus Medical (GMED) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:15am, Wednesday, 05'th Nov 2025
Beyond analysts' top-and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the q
Globus Medical (GMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
11:07am, Thursday, 30'th Oct 2025
Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globus Medical (GMED) to Release Earnings on Thursday
02:42am, Thursday, 30'th Oct 2025
Globus Medical (NYSE: GMED - Get Free Report) is anticipated to post its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Globus Medical to post earnings of $0.79 per
Globus Medical (GMED) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Wednesday, 29'th Oct 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
